Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Before investing in crypto, it's crucial to evaluate various factors to enhance your investment strategy. Discover essential considerations to succeed.
23,028 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Lumentum’s stock surged 1,000% over the past year as AI-driven demand for high-power lasers accelerates. A BNP Pariba...
Lam Research has quietly outpaced rivals in AI tooling, delivering triple-digit gains as 2026 guidance stays upbeat. ...
Gusto, the San Francisco-based HR software maker, posts more than $1 billion in trailing revenue for the last 12 mont...
Lumentum’s fiery stock rally this year has propelled the optics company into the top tier of the market, signaling a ...
Three ETFs can deliver roughly $37,000 a year on a $500,000 portfolio, providing about $3,100 a month without selling...
Colgate-Palmolive posted stronger-than-expected Q1 2026 results, setting the stage for upside despite tariff headwind...
Investors watched spacemobile stock crushed thursday move sharply as AT&T, Verizon, and T-Mobile signaled a bold sate...
A single momentum-driven AI ETF is gaining attention as capex in AI hardware expands. The strategy aims to ride leade...
The White House unveiled a plan to deposit a $1,000 government match into private-sector IRAs for eligible savers sta...
A 21-year-old welder faces a $30,000 vehicle loan at 30% APR. By selling the truck and consolidating into a lower-rat...
Elon Musk’s clash with OpenAI doubles as a bid to launch xAI, with Tesla financing and strategic partnerships setting...